Company Overview and News

23
Venture Capital Deals Of The Week: Space Catapult Edition

2018-06-16 seekingalpha
Welcome to Seeking Alpha’s Venture Capital Deals of the Week. Follow this account and turn on the e-mail alert to receive VCDeals in your inbox on Saturday mornings.
SAP T GOOGL TM TWX CSCO TWC HPE

1
AI is coming to a workplace near you | Euronews

2018-06-14 euronews
Can you imagine sharing your workspace with a little robot? Chatting freely with an AI-powered customer service agent? Or using AI tools to boost profit at your own little startup? Those are some of the visions of an artificial intelligence-powered reality being discussed at The AI Summit in London.
HPE

138
Top Analyst Upgrades and Downgrades: Capital One, Hewlett Packard Enterprises, Kohl’s, Roku, Spotify, Steel Dynamics and More

2018-06-14 247wallst
The futures are trading solidly higher across the board this Thursday morning as the financial world and investors continue to digest yesterday’s commentary from the Federal Reserve. As expected, the Federal Funds rate was increased by 25 basis points or ¼% to 2%, the highest level since 2008, during the financial crisis.
COF.PRG COF.PRH DB UNIT COF.WS TWX MS.PRE COF.PRP MS.PRF MS.PRG MS.PRA HPE WYND COF-D COF-C COF-F AMAT NUS KSS MS COF.PRC COF.PRD COF.PRF TTMI STLD COF-P GSKY XPO KBR COF TWC MS.PRI TEX WRB MS.PRK HMSY ROKU WTI TRI CAKE

1
Foxconn looks to AI after maker of Apple and Amazon products celebrates 30 years in China

2018-06-14 scmp
With 1 million employees and half a dozen factories contributing 4 per cent of the country’s export value, Foxconn’s expansion symbolises China’s role as tech manufacturing powerhouse
HHPG HHPD HPE

159
Broadcom (AVGO), HPE Collaborate To Showcase U.3 Platform

2018-06-13 zacks
Broadcom Inc. (AVGO - Free Report) strengthened its partnership with Hewlett Packard Enterprise Company (HPE - Free Report) in server storage. The companies will collaborate to demonstrate U.3 reference platform, SFF-TA-1001 at HPE Discover. The U.3 universal drive cage will feature Toshiba U.3 facilitated SAS, SATA and NVMe drives. U.3 technology enables SSDs (SATA, SAS and NVMe) and HDDs (SATA and SAS) to function in a single bay.
MU AVGO WDC BRCM HPE

26
7 Women-Led S&P 500 Companies to Own for the Long Haul | InvestorPlace

2018-06-13 investorplace
Just 25% of S&P 500 companies have two or more women on their board of directors. For women looking to become a CEO one day, it’s a big problem.
VTR DUKH HSYFB ULTA PGR DUK KEY ROST BETR HPE KSS SBUX HSY

7
HPE / Hewlett Packard Enterprise Company 11-K

2018-06-12 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
HPE

45
Broadcom Joins Forces with Industry Leaders to Simplify Storage Bay Management

2018-06-12 globenewswire
SAN JOSE, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- Broadcom Inc. (NASDAQ:AVGO) today announced it has co-sponsored and developed the approved SFF-TA-1005 Universal Backplane Management (UBM) specification with Dell EMC and Hewlett Packard Enterprise and 19 other participants, which provides a common management framework for SAS, SATA, and NVMe devices. The SFF-TA-1005 UBM specification will help to unify and standardize backplane management in the data center.
AVGO BRCM HPE

811
The Good Times Are Here to Stay for Advanced Micro Devices, Inc. Stock

2018-06-12 investorplace
Until early March, Advanced Micro Devices, Inc. (NASDAQ:AMD) stock was in a bearish phase. Part of this had to due with the market volatility as well as worries about competitive threats from mega rivals like NVIDIA Corporation (NASDAQ:NVDA) and Intel Corporation (NASDAQ:INTC).
DVMT TCEHY CSCO AMD MSFT TCTZF NVDA INTC BIDU HPE

45
Broadcom and Hewlett Packard Enterprise (HPE) Extend Collaboration in Server Storage

2018-06-12 globenewswire
SAN JOSE, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- Broadcom Inc. (NASDAQ:AVGO) today announced it is extending its collaboration in server storage with Hewlett Packard Enterprise (HPE). Broadcom and HPE will showcase the benefits of the SFF-TA-1001 specification commonly known as U.3 reference platform next week at HPE Discover, with a U.3 universal drive cage demonstration featuring Toshiba U.3-enabled NVMe™, SAS and SATA drives.
AVGO BRCM HPE

119
There Is A Lot Going On Underneath The Market - Cramer's Mad Money (6/11/18)

2018-06-12 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Monday, June 11.
EA SIG SQ KMI.WS RH LLY HPE SIG ATVI EL NKE KMI.PRA KMI TWTR HPQ PLAY KMR UNH CVB KMRFZ

161
SoftBank Vision Fund makes second-ever enterprise software investment

2018-06-11 channelnewsasia
SAN FRANCISCO: The US$100 billion SoftBank Vision Fund has made its second-ever investment in an enterprise software company, as the massive fund broadens its portfolio beyond consumer tech firms such as Uber and DoorDash.
H AAPL HPE

161
SoftBank Vision Fund makes second-ever enterprise software investment

2018-06-11 reuters
SAN FRANCISCO (Reuters) - The $100 billion SoftBank Vision Fund has made its second-ever investment in an enterprise software company, as the massive fund broadens its portfolio beyond consumer tech firms such as Uber and DoorDash.
H AAPL HPE

206
Venture Capital Deals Of The Week: Ant Financial Gets $14B Ahead Of IPO

2018-06-09 seekingalpha
Welcome to Seeking Alpha’s Venture Capital Deals of the Week. Follow this account and turn on the e-mail alert to receive VCDeals in your inbox on Saturday mornings.
IBM JD WDC APPN CG CRM HPE GS BABA DVMT ATHM TROW MSFT NTAP

736
Advanced Micro Devices, Inc. Stock Is Going to Keep Getting Hotter

2018-06-08 investorplace
For the second time (at least), patience has paid off when it comes to Advanced Micro Devices, Inc. (NASDAQ:AMD). AMD spent a few years hovering around $2 per share before skyrocketing in 2016. But last year, the rally faded out; by early April, AMD stock had reached a 16-month low.
TCEHY CSCO AMD TCTZF NVDA INTC HPE

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

10h - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to HPE / Hewlett Packard Enterprise Company on message board site Silicon Investor.

Hewlett Packard Enterprise (HPE) North Coast Productions * Merger with ticker SHPE
Blue Chip Computerware (BCHPE)
CUSIP: 42824C109